Department of Urology, Baoji People's Hospital, Baoji, Shaanxi Province, China.
Department of Urology, Honghui Hospital, Xi'an Jiaotong UniversityWeiyang District, 200 Meters North of the Intersection of Qinhan Avenue and Jianyuan Second Road, Xi'an, Shaanxi Province, 710018, China.
Urolithiasis. 2024 Oct 9;52(1):140. doi: 10.1007/s00240-024-01645-5.
The correlation between novel negative pressure ureteroscopic lithotripsy (NP-URL) combined with flexible ureteroscopy (FU) and percutaneous nephrolithotomy (PCNL) on stone-free rates (SFR) remains unclear. There is a lack of evidence from Chinese populations regarding the relationship between SFR and NP-URL combined with FU (NP-URL-FU) versus PCNL. We aimed to assess the association between NP-URL-FU and PCNL on SFR. We conducted a cohort study involving 166 participants with 2-4 cm kidney stones. Data on SFR (7 days and 2 months) were collected from all participants. Logistic regression analysis was used to substantiate the research objectives. NP-URL-FU versus PCNL showed an 86% decrease in the 7-day SFR (OR = 0.14, 95% CI 0.07-0.29). The results remained stable even after adjusting for potential confounders. However, no statistically significant association was found between the surgical method and the 2-month SFR. Further exploratory subgroup analyses showed no significant interactions, with all P values > 0.05. Among patients with 2-4 cm kidney stones, NP-URL-FU was associated with a lower risk of incident 7-day SFR than PCNL. However, no statistically significant difference was found in the long-term stone removal rate. Therefore, NP-URL-FU may be a viable alternative surgical option for patients seeking minimally invasive procedures.
新型负压力输尿管镜碎石术(NP-URL)联合软性输尿管镜(FU)与经皮肾镜取石术(PCNL)在无石率(SFR)方面的相关性尚不清楚。对于 NP-URL 联合 FU(NP-URL-FU)与 PCNL 之间的 SFR 关系,中国人群缺乏相关证据。我们旨在评估 NP-URL-FU 与 PCNL 在 SFR 方面的相关性。我们进行了一项队列研究,纳入了 166 名 2-4cm 肾结石患者。所有参与者的 SFR(7 天和 2 个月)数据均被收集。采用逻辑回归分析来证实研究目标。NP-URL-FU 与 PCNL 相比,7 天 SFR 降低了 86%(OR=0.14,95%CI 0.07-0.29)。即使在调整了潜在混杂因素后,结果仍然稳定。然而,手术方法与 2 个月 SFR 之间没有统计学上的显著关联。进一步的探索性亚组分析显示,没有显著的交互作用,所有 P 值均>0.05。在 2-4cm 肾结石患者中,NP-URL-FU 与较低的 7 天 SFR 风险相关,而与 PCNL 相比,其长期结石清除率无统计学差异。因此,NP-URL-FU 可能是一种有前途的微创治疗选择。